Literature DB >> 6745296

The rational use of 201Tl scintigraphy in the evaluation of differentiated thyroid cancer.

J Nĕmec, V Zamrazil, D Pohunková, S Röhling, V Holub.   

Abstract

Fifteen patients with differentiated thyroid cancer were examined following 131I thyroid ablation, of these seven were examined after radio-iodine therapy to disseminated neck cancer. They had no further radio-iodine uptake and were evaluated using a 201Tl scan. In thirteen patients there was a good correlation between the results and the clinical diagnosis, showing no uptake in seven subjects with negative clinical findings, and positive delineation of tumour tissue in the neck region in six patients. The remaining two patients with lymph node metastases after previous radio-iodine irradiation showed marked clinical regression of the metastases with absent uptake of both 131I and 201Tl, probably due to radiation-induced changes. The comparison of thallium scans with plasma thyroglobulin levels showed certain differences (high plasma thyroglobulin without any proof of remaining thyroid tissue in one patient and normal/low plasma thyroglobulin in the presence of a tumour in two patients) but both measurements could give additional information. It is believed that while in the differential diagnosis of a thyroid nodule no important information could be expected of scanning (compared with the high value of aspiration biopsy), the evaluation of patients without 131I uptake by 201Tl scans could provide important information for further therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745296     DOI: 10.1007/BF00803247

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

1.  Thallium-201 distribution in the thyroid: relationship to thyroidal trapping function.

Authors:  Z H Oster; H W Strauss; K Harrison; H D Burns; B Pitt
Journal:  Radiology       Date:  1978-03       Impact factor: 11.105

2.  Uptake of thallium-201 in enlarged thyroid glands: concise communication.

Authors:  M Fukuchi; A Kido; K Hyodo; K Tachibana; K Onoue; T Morita; K Nagai
Journal:  J Nucl Med       Date:  1979-08       Impact factor: 10.057

3.  Computerized study with 201T1 of the cold thyroid node.

Authors:  F Palermo; B Saitta; F Coghetto; M Tiberio; L Caldato
Journal:  Nuklearmedizin       Date:  1982-02       Impact factor: 1.379

4.  Clinical evaluation of 201-thallium chloride scan for thyroid nodule.

Authors:  P Pavoni; L Mango
Journal:  Eur J Nucl Med       Date:  1981-01

5.  Clinical evaluation of 201thallium chloride scan for thyroid nodule.

Authors:  T Harada; Y Ito; K Shimaoka; T Taniguchi; A Matsudo; T Senoo
Journal:  Eur J Nucl Med       Date:  1980-04

6.  Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.

Authors:  O Senga; M Miyakawa; H Shirota; M Makiuchi; K Yano; M Miyazawa; M Takizawa
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

7.  Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma.

Authors:  J Bednár; J Nĕmec; V Zamrazil; S Vána; D Pohunková; S Röhling
Journal:  Nuklearmedizin       Date:  1983-08       Impact factor: 1.379

8.  201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.

Authors:  N Tonami; K Hisada
Journal:  Radiology       Date:  1980-08       Impact factor: 11.105

9.  Scintigraphy with 201Tl for detection of thyroid cancer metastases.

Authors:  D A Piers; W J Sluiter; P H Willemse; H Doorenbos
Journal:  Eur J Nucl Med       Date:  1982

10.  Clinical evaluation of tumor imaging with 201 TI chloride.

Authors:  K Hisada; N Tonami; T Miyamae; Y Hiraki; T Yamazaki; T Maeda; M Nakajo
Journal:  Radiology       Date:  1978-11       Impact factor: 11.105

View more
  1 in total

1.  Paradoxical technetium-thallium subtraction scan in a case of parathyroid adenoma.

Authors:  G Bedig; E Sarfati; P Valensi; P Tellier; F Paycha; M Vulpillat
Journal:  Eur J Nucl Med       Date:  1985
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.